Inventor · disambiguated record
Vidal F. De La Cruz
Also filed as: DE LA CRUZ JR VIDAL F · DE LA CRUZ JR VIDAL FELIX · DE LA CRUZ VIDAL · DE LA CRUZ VIDAL F
7 granted patents·10 pending applications·10 citations·filing 1993–2024
74Inventor score
Files withIBEX BIOSCIENCES INC5CYTOKINE PHARMASCIENCES INC2AAB THERAPEUTICS LLC1BAXTER INTERNAT S A1CORETECH INC1
Top patents by PatentIndex Score
17 records- 0173US2025296990A1Antibodies and therapeutic uses thereofIBEX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0267US2025057978A1Use of pcbp1 to treat hyperproliferative diseaseIBEX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0362US12173057B2Antibodies and therapeutic uses thereofIBEX BIOSCIENCES INC·Filed 2019·Granted Dec 24, 2024·0 cites·44 claims
- 0456US11980670B2Use of PCBP1 to treat hyperproliferative diseaseIBEX BIOSCIENCES INC·Filed 2019·Granted May 14, 2024·0 cites·24 claims
- 0555US12390485B2Compounds and methods for suppressing an immune response to substances containing polyethylene glycolAAB THERAPEUTICS LLC·Filed 2022·Granted Aug 19, 2025·0 cites·18 claims
- 0655US2008113997A1Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factorCYTOKINE PHARMASCIENCES INC·Filed 2007·Application pending·0 cites
- 0754US2024010723A1Antibodies targeted to cd147IBEX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0851US8747843B2Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factorGIROIR BRETT P·Filed 2007·Granted Jun 10, 2014·0 cites·4 claims
- 0951US2022228126A1Use of pcbp1 to generate induced pluripotent stem cells while inhibiting oncogenesisIBEX BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 1050US7795314B2Protective role of semapimod in necrotizing enterocolitisCYTOKINE PHARMASCIENCES INC·Filed 2006·Granted Sep 14, 2010·0 cites·9 claims
- 1150US2015017179A1Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant FactorBAXTER INTERNAT S A·Filed 2014·Application pending·0 cites
- 1250US2013225586A1Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factorCPSI STOCKHOLDER TRUST·Filed 2012·Application pending·0 cites
- 1348US2005202010A1Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factorFiled 2004·Application pending·0 cites
- 1444US2005250826A1Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factorSIELECKI-DZURDZ THAIS·Filed 2005·Application pending·0 cites
- 1541US8314149B2Protective role of semapimod in necrotizing enterocolitisZAMORA RUBEN·Filed 2010·Granted Nov 20, 2012·0 cites·5 claims
- 1641US5599912ACompounds and methods for suppressing an immune response to sulfomethoxozale containing substancesCORETECH INC·Filed 1993·Granted Feb 4, 1997·10 cites·7 claims
- 1732US2013197081A1Intravaginal administration of misoprostolPOWERS BARBARA L·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →